To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene EGFRTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
289 supporting clones for gene EGFR back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AW163038 brain, frontal lobe .a 1 to 645 1 to 646   tiling clone,   646/646
(100 %)
21 diff
(96.8 %id)
NM_005228.3   .a 1 to 5599 1 to 5599 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 5599/5599
(100 %)
1 diff
(100.0 %id)
CF994830 Human Placenta, placenta .a 39 to 738 25 to 732       708/815
(86 %)
21 diff
(97.5 %id)
X00588   .a 70 to 5594 11 to 5532 N540K tiling clone,   5522/5532
(99 %)
20 diff
(99.7 %id)
BC070081 Placenta, normal .a 73 to 4160 1 to 4087 N1107I P1108L V1109S Y1110I H1111T ... available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 4087/4087
(100 %)
3 diff
(100.0 %id)
CD109792 Human Placenta, placenta .a 73 to 831 28 to 792   available from MGC,   765/792
(96 %)
15 diff
(98.2 %id)
AU099322   .a 75 to 374 1 to 300       300/300
(100 %)
0 diff
(100 %id)
AU105293   .a 75 to 124 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BP255451 Kidney .a 75 to 656 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP320759 placenta .a 76 to 699 1 to 624       624/624
(100 %)
1 diff
(99.9 %id)
AU105294   .a 86 to 135 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BP256444 Kidney .a 86 to 671 1 to 587       587/588
(99 %)
2 diff
(99.7 %id)
CB988966 Human Placenta, placenta .a 88 to 762 24 to 704       681/791
(86 %)
18 diff
(97.8 %id)
AB209442 brain .a 101 to 4151 1 to 4050 N158M V159W E160R S161A I162S ...     4050/4050
(100 %)
4 diff
(100.0 %id)
AI935313 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 102 to 858 1 to 757     Submitted on the opposite strand 757/757
(100 %)
11 diff
(98.6 %id)
AK290352 tongue, tumor tissue .a 201 to 4132 1 to 3932 Y891H Y915C     3932/3932
(100 %)
6 diff
(99.9 %id)
AY550966   .a 201 to 3893 1 to 3693 G33C     3693/3693
(100 %)
2 diff
(100.0 %id)
DQ088980   .a 201 to 3935 1 to 3735 S1104P tiling clone,   3735/3735
(100 %)
3 diff
(100.0 %id)
AY698023   .a 247 to 2181 1 to 1935       1935/1935
(100 %)
2 diff
(99.9 %id)
AU140518 placenta .a 564 to 1340 2 to 777   capped   776/778
(99 %)
10 diff
(98.8 %id)
X00663   .a 673 to 3072 1 to 2400       2400/2400
(100 %)
2 diff
(100.0 %id)
BC118665 PCR rescued clones .a 883 to 2255 19 to 1391       1373/1395
(98 %)
13 diff
(99.1 %id)
BC128419 PCR rescued clones .a 1081 to 2216 20 to 1156       1137/1165
(97 %)
10 diff
(99.2 %id)
BE272152 adenocarcinoma cell line, ovary .a 1589 to 2382 35 to 822       788/960
(82 %)
19 diff
(98.1 %id)
BE747584 adenocarcinoma cell line, ovary .a 1589 to 2422 23 to 858       836/969
(86 %)
25 diff
(97.5 %id)
CV574341 cornea, eye .a 1605 to 2230 630 to 5     Submitted on the opposite strand 626/630
(99 %)
1 diff
(99.9 %id)
BE315382 adenocarcinoma cell line, ovary .a 1608 to 2283 1 to 672       672/736
(91 %)
13 diff
(98.3 %id)
BE740357 adenocarcinoma cell line, ovary .a 1608 to 2238 1 to 634       634/634
(100 %)
3 diff
(99.6 %id)
BE260467 brain, neuroblastoma .a 1752 to 2523 1 to 773       773/784
(98 %)
29 diff
(96.4 %id)
BE744284 adenocarcinoma cell line, ovary .a 1993 to 2716 1 to 727       727/890
(81 %)
7 diff
(99.3 %id)
BE745530 adenocarcinoma cell line, ovary .a 1994 to 2792 1 to 798       798/935
(85 %)
11 diff
(98.9 %id)
BE746257 adenocarcinoma cell line, ovary .a 1994 to 2681 1 to 684       684/684
(100 %)
4 diff
(99.5 %id)
ES310555 scalp interfollicular dermis, skin .a 2243 to 2892 1 to 648       648/648
(100 %)
7 diff
(99.0 %id)
AA234783 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2409 to 2847 1 to 438       438/438
(100 %)
5 diff
(98.9 %id)
BX100168 liver and spleen .a 2926 to 3665 1 to 740   tiling clone,   740/740
(100 %)
2 diff
(99.8 %id)
BF989577 placenta_normal .a 2947 to 3170 228 to 6       221/242
(91 %)
1 diff
(99.6 %id)
BF999347 placenta_normal .a 2947 to 3170 228 to 6       221/242
(91 %)
1 diff
(99.6 %id)
BE732282 choriocarcinoma, placenta .a 2990 to 3695 1 to 702       702/766
(91 %)
21 diff
(97.3 %id)
CV574072 cornea, eye .a 3082 to 3723 1 to 642       642/642
(100 %)
1 diff
(99.9 %id)
CU453116 epidermis .a 3100 to 3583 516 to 33     Submitted on the opposite strand 484/516
(93 %)
1 diff
(99.9 %id)
BM703536 eye, human retina .a 3144 to 3727 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BM715282 eye, human retina .a 3144 to 3838 1 to 695       695/695
(100 %)
0 diff
(100 %id)
BF727163 eye, lens .a 3224 to 3743 1 to 520       520/520
(100 %)
0 diff
(100 %id)
AA236408 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3333 to 3760 1 to 428   fully sequenced,   428/428
(100 %)
4 diff
(99.1 %id)
AA228049 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3333 to 3714 1 to 381   fully sequenced,   381/381
(100 %)
1 diff
(99.8 %id)
CV574329 cornea, eye .a 3415 to 4057 1 to 643       643/643
(100 %)
1 diff
(99.9 %id)
BU622138 Cell Line, Chondrosarcoma .a 3431 to 4160 749 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 731/731
(100 %)
2 diff
(99.8 %id)
TI_154021740   .a 3447 to 4160 809 to 95   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 715/716
(99 %)
6 diff
(99.2 %id)
BQ575631 Chondrosarcoma Grade II, Left Pelvis .a 3481 to 4160 699 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 681/681
(100 %)
1 diff
(99.9 %id)
AW157070 brain, frontal lobe .a 3508 to 4167 660 to 1       660/684
(96 %)
15 diff
(97.9 %id)
AW510767 pooled .a 3517 to 4159 643 to 1       643/655
(98 %)
0 diff
(100 %id)
CA438692 lung, Metastatic Chondrosarcoma .a 3517 to 4160 664 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 646/647
(99 %)
3 diff
(99.6 %id)
AA587386 colon, colon tumor RER+ .a 3537 to 4160 623 to 1       623/623
(100 %)
3 diff
(99.6 %id)
BQ019748 Chondrosarcoma, Left Pubic Bone .a 3559 to 4160 620 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 602/602
(100 %)
3 diff
(99.6 %id)
FN120909 breast carcinoma .a 3568 to 3669 102 to 1     Submitted on the opposite strand 102/102
(100 %)
3 diff
(97.1 %id)
BM742695 stomach .a 3575 to 4130 1 to 556       556/556
(100 %)
0 diff
(100 %id)
BM783418 stomach .a 3575 to 4249 1 to 676       676/676
(100 %)
1 diff
(99.9 %id)
BF992436 placenta_normal .a 3617 to 3781 1 to 165       165/165
(100 %)
0 diff
(100 %id)
AU158531 placenta .a 3621 to 4160 540 to 1       540/543
(99 %)
12 diff
(97.8 %id)
EC468409 Prostate .a 3636 to 3733 1 to 97       97/97
(100 %)
6 diff
(93.9 %id)
EC483025 Prostate .a 3636 to 3725 1 to 87       87/93
(93 %)
5 diff
(94.7 %id)
AI744605 pooled .a 3637 to 4161 525 to 1       525/525
(100 %)
0 diff
(100 %id)
EC453902 Prostate .a 3638 to 3732 1 to 91       91/91
(100 %)
6 diff
(93.5 %id)
EC555788 Prostate .a 3638 to 3733 1 to 96       96/96
(100 %)
0 diff
(100 %id)
EC468453 Prostate .a 3641 to 3733 7 to 95       89/95
(93 %)
6 diff
(93.7 %id)
EC555673 Prostate .a 3646 to 3725 14 to 92       79/98
(80 %)
2 diff
(98.0 %id)
AI301624 carcinoid, lung .a 3661 to 4159 499 to 1       499/499
(100 %)
0 diff
(100 %id)
AA228011 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3684 to 4160 475 to 1   fully sequenced,   475/475
(100 %)
5 diff
(99.0 %id)
TI_157612195   .a 3697 to 4182 554 to 67       488/555
(87 %)
0 diff
(100 %id)
AA234715 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3727 to 4160 434 to 1       434/434
(100 %)
2 diff
(99.6 %id)
AA236409 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3730 to 4160 431 to 1   fully sequenced,   431/431
(100 %)
1 diff
(99.8 %id)
FN046153 breast carcinoma .a 3759 to 3851 1 to 92       92/92
(100 %)
2 diff
(97.9 %id)
BU729500 eye, human retina .a 3795 to 4160 385 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 367/367
(100 %)
3 diff
(99.2 %id)
BU752129 placenta .a 3822 to 4160 357 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 339/339
(100 %)
0 diff
(100 %id)
BF432992 carcinoid, lung .a 3833 to 4165 333 to 1       333/333
(100 %)
0 diff
(100 %id)
BQ896741 sympathetic trunk .a 3865 to 4160 1 to 296   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 296/296
(100 %)
0 diff
(100 %id)
BG222223 moderate to poorly differentiated invasivecarcinoma, tongue .a 4009 to 4173 189 to 24       166/189
(87 %)
0 diff
(100 %id)
CN289874 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 4053 to 4816 13 to 775   tiling clone,   763/775
(98 %)
6 diff
(99.3 %id)
AA904331 carcinoid, lung .a 4057 to 4159 103 to 1       103/103
(100 %)
0 diff
(100 %id)
TI_154129960   .a 4069 to 4924 958 to 114       845/1066
(79 %)
0 diff
(100 %id)
BG750278 eye, normal pigmented retinal epithelium .a 4256 to 5070 1 to 823       823/823
(100 %)
28 diff
(96.6 %id)
BG571775 placenta .a 4549 to 5451 1 to 906       906/973
(93 %)
31 diff
(96.9 %id)
AL598260   .a 4573 to 5038 1 to 466       466/466
(100 %)
0 diff
(100 %id)
BF341671 brain, glioblastoma with EGFR amplification .a 4621 to 5348 1 to 722       722/722
(100 %)
10 diff
(98.7 %id)
DA461767 tongue, tumor tissue .a 4627 to 5196 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA802649 brain .a 4634 to 5180 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA802709 brain .a 4634 to 5192 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB062607 testis .a 4638 to 5188 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BC134346 PCR rescued clones .a 4711 to 4806 5 to 100       96/100
(96 %)
6 diff
(94.0 %id)
BM695834 eye, human retina .a 4711 to 4938 1 to 228     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 228/228
(100 %)
0 diff
(100 %id)
W48712 senescent fibroblast .a 4738 to 5214 1 to 478   fully sequenced, Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 478/478
(100 %)
1 diff
(99.8 %id)
BP358679 mammary gland .a 4805 to 5388 1 to 584   tiling clone,   584/584
(100 %)
3 diff
(99.5 %id)
TI_57183296   .a 4857 to 5668 33 to 839       807/839
(96 %)
6 diff
(99.3 %id)
BI769878 pooled lung and spleen .a 4861 to 5668 1 to 803       803/803
(100 %)
7 diff
(99.2 %id)
AI217671 pooled .a 4966 to 5384 419 to 1       419/419
(100 %)
0 diff
(100 %id)
CR603510 Placenta Cot 25-normalized .a 4993 to 5595 1 to 603       603/603
(100 %)
0 diff
(100 %id)
TI_157612893   .a 5021 to 5594 693 to 117   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 577/750
(76 %)
24 diff
(96.8 %id)
BG287839 bladder, transitional cell papilloma, cell line .a 5103 to 5876 1 to 767       767/1061
(72 %)
23 diff
(97.9 %id)
H80438 liver and spleen .a 5116 to 5369 1 to 254       254/254
(100 %)
0 diff
(100 %id)
BG987918 head_neck .a 5127 to 5305 25 to 204       180/218
(82 %)
10 diff
(95.5 %id)
W48713 senescent fibroblast .a 5184 to 5599 436 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 419/419
(100 %)
8 diff
(98.1 %id)
AW262127 lung, two pooled squamous cell carcinomas .a 5193 to 5599 407 to 1       407/407
(100 %)
0 diff
(100 %id)
BM666922 eye, human retina .a 5199 to 5594 416 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 398/398
(100 %)
2 diff
(99.5 %id)
AL041799 testis .a 5204 to 5794 1 to 591       591/591
(100 %)
0 diff
(100 %id)
BM830628 stomach .a 5240 to 5792 1 to 553       553/553
(100 %)
0 diff
(100 %id)
FN142732 breast carcinoma .a 5289 to 5384 1 to 95       95/95
(100 %)
1 diff
(99.0 %id)
AA702764 liver and spleen .a 5311 to 5599 289 to 1       289/289
(100 %)
0 diff
(100 %id)
CB268886 adipose .a 5344 to 5885 1 to 542       542/542
(100 %)
0 diff
(100 %id)
CB269761 adipose .a 5346 to 5894 1 to 549   tiling clone,   549/549
(100 %)
0 diff
(100 %id)
DA437265 tongue, tumor tissue .a 5410 to 6027 2 to 619   capped   618/618
(100 %)
0 diff
(100 %id)
DA857807 placenta .a 5481 to 6018 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
AI918180 anaplastic oligodendroglioma, brain .a 5497 to 5600 118 to 15       104/118
(88 %)
0 diff
(100 %id)
DA371223 thalamus .a 5598 to 6146 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA856858 placenta .a 5627 to 6201 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA859167 placenta .a 5677 to 6231 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BQ018947 lung, Metastatic Chondrosarcoma .a 5709 to 6341 651 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 633/641
(98 %)
1 diff
(99.9 %id)
AI700517 carcinoid, lung .a 5738 to 6342 605 to 1       605/605
(100 %)
1 diff
(99.9 %id)
DA856277 placenta .a 5755 to 6339 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
TI_154089803   .a 5799 to 6341 664 to 116   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 549/1057
(51 %)
46 diff
(95.7 %id)
CN369784 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 5810 to 6451 1 to 642   tiling clone,   642/642
(100 %)
2 diff
(99.7 %id)
AI148326 uterus .a 5892 to 6341 450 to 1       450/450
(100 %)
0 diff
(100 %id)
BE769557 prostate_tumor .a 5975 to 6281 26 to 342       317/357
(88 %)
30 diff
(91.6 %id)
AA463742 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 5989 to 6334 346 to 1       346/346
(100 %)
0 diff
(100 %id)
DB162231 thymus .a 6030 to 6639 2 to 612   capped   611/611
(100 %)
2 diff
(99.7 %id)
H80439 liver and spleen .a 6103 to 6307 205 to 1       205/205
(100 %)
0 diff
(100 %id)
CN369783 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 6116 to 6864 1 to 749   tiling clone,   749/749
(100 %)
1 diff
(99.9 %id)
CN481936 eye .a 6257 to 6867 1 to 611   tiling clone,   611/611
(100 %)
2 diff
(99.7 %id)
DC348276 tongue, tumor tissue .b 1 to 574 1 to 574   tiling clone,   574/574
(100 %)
0 diff
(100 %id)
DC347326 tongue, tumor tissue .b 95 to 677 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DC348244 tongue, tumor tissue .b 117 to 691 1 to 577       577/577
(100 %)
3 diff
(99.5 %id)
AK294750 brain .b 125 to 4062 1 to 3938 N647S tiling clone,   3938/3938
(100 %)
3 diff
(100.0 %id)
DC321096 brain .b 125 to 715 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
DC346639 tongue, tumor tissue .b 129 to 687 1 to 559       559/559
(100 %)
2 diff
(99.7 %id)
DC347349 tongue, tumor tissue .b 135 to 730 1 to 597       597/597
(100 %)
4 diff
(99.4 %id)
NM_201284.1   .c 1 to 2865 1 to 2865 exact RefSeq,   2865/2865
(100 %)
0 diff
(100 %id)
AF125253 placenta .c 2 to 2865 1 to 2864 exact tiling clone,   2864/2864
(100 %)
2 diff
(100.0 %id)
K03193   .d 1 to 2506 1 to 2503 exact tiling clone,   2503/2643
(94 %)
10 diff
(99.7 %id)
AI554567 anaplastic oligodendroglioma, brain .d 7 to 685 1 to 678     Submitted on the opposite strand 678/678
(100 %)
2 diff
(99.8 %id)
AI740805 pooled .d 7 to 813 1 to 805   tiling clone, Submitted on the opposite strand 805/805
(100 %)
13 diff
(98.4 %id)
BE327106 carcinoid, lung .d 7 to 450 1 to 444     Submitted on the opposite strand 444/444
(100 %)
0 diff
(100 %id)
BF056131 pooled .d 7 to 481 1 to 475     Submitted on the opposite strand 475/475
(100 %)
0 diff
(100 %id)
TI_158435948   .d 7 to 514 65 to 572     Submitted on the opposite strand 508/998
(50 %)
7 diff
(99.3 %id)
AI761585 pooled .d 34 to 833 1 to 798     Submitted on the opposite strand 796/798
(99 %)
11 diff
(98.7 %id)
DA852778 placenta .d 117 to 650 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
EL948609 eyeball .d 247 to 695 119 to 568       450/568
(79 %)
8 diff
(98.6 %id)
CN289873 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 531 to 1256 1 to 726       726/726
(100 %)
0 diff
(100 %id)
DA439033 tongue, tumor tissue .d 544 to 1134 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DA440596 tongue, tumor tissue .d 579 to 1083 2 to 506   capped   505/505
(100 %)
6 diff
(98.9 %id)
DB138707 thymus .d 587 to 1116 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
DA458037 tongue, tumor tissue .d 674 to 1221 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA455875 tongue, tumor tissue .d 800 to 1360 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
CF786111 mixed .d 1185 to 1847 1 to 662       662/805
(82 %)
8 diff
(99.1 %id)
CK001003 mixed .d 1192 to 1898 33 to 739       707/739
(95 %)
6 diff
(99.2 %id)
DA551883   .d 1224 to 1739 2 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
DA445055 tongue, tumor tissue .d 1417 to 1969 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BM832712 stomach .d 1538 to 2047 1 to 510       510/510
(100 %)
0 diff
(100 %id)
NM_201282.1   .e 1 to 2239 1 to 2239 exact RefSeq,   2239/2239
(100 %)
0 diff
(100 %id)
AF277897   .e 2041 to 2239 1 to 199   tiling clone,   199/199
(100 %)
0 diff
(100 %id)
U95089 placenta .f 1 to 1733 96 to 1827 exact tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1732/1827
(94 %)
7 diff
(99.7 %id)
NM_201283.1   .f 164 to 1733 1 to 1570 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1570/1570
(100 %)
0 diff
(100 %id)
U48722 placenta .f 166 to 1733 1 to 1568 exact tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1568/1568
(100 %)
2 diff
(99.9 %id)
AY698024   .f 410 to 1627 1 to 1218 exact tiling clone,   1218/1218
(100 %)
0 diff
(100 %id)
AA701271 liver and spleen .f 1259 to 1722 464 to 1       464/464
(100 %)
4 diff
(99.2 %id)
AA705706 liver and spleen .f 1304 to 1722 416 to 1       416/416
(100 %)
6 diff
(98.6 %id)
BC057802 Placenta, pre-eclamptic .g-u 1 to 2170 1 to 2170 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2170/2170
(100 %)
2 diff
(100.0 %id)
CB988394 Human Placenta, placenta .g-u 88 to 660 27 to 606       580/854
(67 %)
10 diff
(98.9 %id)
BP276096 Kidney .g-u 90 to 474 1 to 385       385/581
(66 %)
4 diff
(99.4 %id)
BQ685689 ductal carcinoma, cell line, Pancreas .g-u 812 to 1670 1 to 872       872/969
(89 %)
27 diff
(97.3 %id)
TI_149287903   .g-u 1115 to 1892 833 to 62       772/1059
(72 %)
0 diff
(100 %id)
BM970083 lung .g-u 1266 to 1869 624 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 606/606
(100 %)
3 diff
(99.6 %id)
BM826022 Ascites, stomach .g-u 1479 to 1791 1 to 313       313/313
(100 %)
3 diff
(99.1 %id)
DA517004 brain .g-u 1508 to 2034 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
R35059 placenta .g-u 1510 to 1885 1 to 407       407/407
(100 %)
60 diff
(85.3 %id)
CK430299 eye, lacrimal gland .g-u 1523 to 2144 1 to 626       626/626
(100 %)
3 diff
(99.6 %id)
AA768080 Prostate, tumor .g-u 1545 to 1722 1 to 178       178/178
(100 %)
0 diff
(100 %id)
BX501698 Liver .g-u 1612 to 2128 1 to 518       518/518
(100 %)
1 diff
(99.9 %id)
AW261991 lung, two pooled squamous cell carcinomas .g-u 1904 to 2356 463 to 11   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 453/453
(100 %)
0 diff
(100 %id)
R77147 placenta .g-u 2050 to 2444 400 to 1       400/400
(100 %)
8 diff
(98.0 %id)
CA313202 Human Lung Epithelial cells, lung .g-u 2121 to 2473 371 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 353/361
(97 %)
0 diff
(100 %id)
EF210210   .h 1 to 414 1 to 414 exact tiling clone,   414/414
(100 %)
1 diff
(99.8 %id)
AL601060   .i-u 1 to 501 1 to 501 exact tiling clone,   501/501
(100 %)
1 diff
(99.9 %id)
AK127817 placenta .j 1 to 1872 2 to 1873 exact tiling clone, available from FLJ,   1873/1873
(100 %)
5 diff
(99.8 %id)
DA836320 placenta .j 1 to 549 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
AW665045 pooled .j 464 to 845 1 to 382   tiling clone, Submitted on the opposite strand 382/382
(100 %)
3 diff
(99.3 %id)
AW779088 pooled .j 464 to 850 1 to 386     Submitted on the opposite strand 386/386
(100 %)
4 diff
(99.0 %id)
AA906114 pooled .j 767 to 843 1 to 77     Submitted on the opposite strand 77/77
(100 %)
3 diff
(96.2 %id)
AA078668 placenta .j 1057 to 1196 1 to 140       140/235
(59 %)
2 diff
(99.2 %id)
DB328236 placenta .j 1395 to 1872 480 to 1       480/480
(100 %)
4 diff
(99.2 %id)
AA934507 carcinoid, lung .k 1 to 455 1 to 444 R3P P4X T7K T8S G9R ... tiling clone, Submitted on the opposite strand 444/444
(100 %)
33 diff
(92.6 %id)
AW170373 cervix, tumor .l 1 to 561 1 to 561 exact tiling clone, Submitted on the opposite strand 561/561
(100 %)
1 diff
(99.9 %id)
EF210211   .m 1 to 256 1 to 256 exact tiling clone,   256/256
(100 %)
0 diff
(100 %id)
DA443399 tongue, tumor tissue .n-u 1 to 596 2 to 597   tiling clone, capped   596/596
(100 %)
1 diff
(99.9 %id)
GU228573   .n-u 3 to 359 1 to 357   tiling clone,   357/357
(100 %)
0 diff
(100 %id)
BJ997943 Wilms tumor .n-u 89 to 688 1 to 600   tiling clone,   600/600
(100 %)
3 diff
(99.5 %id)
BG419484 Kidney, renal cell adenocarcinoma .n-u 431 to 1133 1 to 700       700/974
(71 %)
19 diff
(98.1 %id)
CK429563 eye, lacrimal gland .n-u 495 to 1129 1 to 636       636/636
(100 %)
1 diff
(99.9 %id)
CA391889 eye, RPE/choroid .n-u 532 to 1155 1 to 625       625/625
(100 %)
2 diff
(99.7 %id)
CB131985 Liver .n-u 572 to 1104 1 to 533       533/533
(100 %)
0 diff
(100 %id)
DA887453   .n-u 683 to 1242 2 to 561 exact tiling clone, capped   560/560
(100 %)
0 diff
(100 %id)
DA454563 tongue, tumor tissue .n-u 965 to 1528 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
AA333063 Embryo, 8 weeks .n-u 1033 to 1329 1 to 297       297/297
(100 %)
0 diff
(100 %id)
CV572365 cornea, eye .n-u 1058 to 1667 1 to 610       610/610
(100 %)
0 diff
(100 %id)
CU450680 epidermis .n-u 1059 to 1841 798 to 16   tiling clone, Submitted on the opposite strand 783/798
(98 %)
0 diff
(100 %id)
BQ637472 eye, retina .n-u 1072 to 1698 1 to 627       627/627
(100 %)
0 diff
(100 %id)
TI_57229720   .n-u 1096 to 1829 82 to 806       725/727
(99 %)
23 diff
(96.9 %id)
CD671692 eye, Iris .n-u 1109 to 1769 1 to 661       661/661
(100 %)
0 diff
(100 %id)
AL598566   .n-u 1121 to 1737 1 to 620       620/620
(100 %)
4 diff
(99.4 %id)
BM794678 Ascites, stomach .n-u 1140 to 1704 1 to 565   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 565/565
(100 %)
0 diff
(100 %id)
DA826408 pericardium .n-u 1165 to 1734 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
CU447473 epidermis .n-u 1180 to 1601 422 to 1     Submitted on the opposite strand 422/422
(100 %)
4 diff
(99.1 %id)
U51732 placenta .n-u 1312 to 1763 8 to 458       451/458
(98 %)
6 diff
(98.7 %id)
AK026818 Human lung .n-u 1418 to 3513 1 to 2097   available from FLJ, AAA   2097/2097
(100 %)
6 diff
(99.8 %id)
GU228584   .n-u 1427 to 2231 1 to 805       805/805
(100 %)
0 diff
(100 %id)
CB999872 Pooled-Skin .n-u 1476 to 2195 1 to 728       728/729
(99 %)
21 diff
(97.2 %id)
BG611929 adenocarcinoma, Prostate .n-u 1492 to 2098 1 to 607       607/982
(61 %)
3 diff
(99.7 %id)
CN361259 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n-u 1510 to 2251 1 to 742   tiling clone,   742/742
(100 %)
1 diff
(99.9 %id)
BG163827 hypernephroma, cell line, Kidney .n-u 1560 to 2301 43 to 781       739/904
(81 %)
6 diff
(99.4 %id)
DA568891 whole embryo, mainly head .n-u 1628 to 2429 2 to 802   capped   801/844
(94 %)
7 diff
(99.2 %id)
BX507091 Liver .n-u 1681 to 2329 1 to 649       649/649
(100 %)
3 diff
(99.6 %id)
BG676803 skin, squamous cell carcinoma .n-u 1706 to 2580 1 to 876       876/879
(99 %)
14 diff
(98.5 %id)
BG676616 skin, squamous cell carcinoma .n-u 1706 to 2586 1 to 886       886/892
(99 %)
14 diff
(98.5 %id)
BQ695098 adipose .n-u 1821 to 2444 1 to 624       624/624
(100 %)
3 diff
(99.6 %id)
BG483075 lung .n-u 1883 to 2594 1 to 716       716/787
(90 %)
21 diff
(97.4 %id)
BG169533 hypernephroma, cell line, Kidney .n-u 1967 to 2693 1 to 726       726/735
(98 %)
14 diff
(98.1 %id)
BM768072 Ascites, stomach .n-u 1994 to 2652 1 to 659       659/659
(100 %)
0 diff
(100 %id)
BM770220 Ascites, stomach .n-u 1994 to 2489 1 to 496       496/496
(100 %)
0 diff
(100 %id)
BF348005 anaplastic oligodendroglioma with 1p/19qloss, brain .n-u 2004 to 2811 1 to 805       805/808
(99 %)
20 diff
(97.6 %id)
BM843413 lymph node, stomach .n-u 2064 to 2735 1 to 672       672/672
(100 %)
1 diff
(99.9 %id)
BG623115 placenta .n-u 2158 to 2886 1 to 732       732/733
(99 %)
6 diff
(99.2 %id)
BG678762 skin, squamous cell carcinoma .n-u 2187 to 3047 1 to 867       867/960
(90 %)
11 diff
(98.9 %id)
BG619090 placenta .n-u 2190 to 2862 1 to 671       671/673
(99 %)
3 diff
(99.6 %id)
BM743093 stomach .n-u 2190 to 2804 1 to 615       615/615
(100 %)
0 diff
(100 %id)
BM747582 stomach .n-u 2190 to 2742 1 to 553       553/553
(100 %)
0 diff
(100 %id)
BG675345 skin .n-u 2215 to 2989 1 to 781   tiling clone,   781/1035
(75 %)
10 diff
(99.1 %id)
W92896 liver and spleen .n-u 2389 to 2811 1 to 424       424/424
(100 %)
1 diff
(99.8 %id)
BG171546 hypernephroma, cell line, Kidney .n-u 2398 to 3131 1 to 735       735/738
(99 %)
14 diff
(98.2 %id)
TI_154105057   .n-u 2418 to 3122 788 to 84   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 705/705
(100 %)
0 diff
(100 %id)
CA446345 Chondrosarcoma, Left Pubic Bone .n-u 2439 to 3122 702 to 19   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 684/684
(100 %)
0 diff
(100 %id)
BE878463 large cell carcinoma, undifferentiated, lung .n-u 2451 to 3191 1 to 747       747/847
(88 %)
14 diff
(98.4 %id)
BG570936 placenta .n-u 2452 to 3267 1 to 809       809/847
(95 %)
16 diff
(98.2 %id)
BG621762 placenta .n-u 2481 to 3254 1 to 774       774/801
(96 %)
13 diff
(98.4 %id)
BX108964 liver and spleen .n-u 2496 to 3214 1 to 719       719/719
(100 %)
0 diff
(100 %id)
CR738520 liver and spleen .n-u 2496 to 3214 1 to 719       719/719
(100 %)
0 diff
(100 %id)
BM746312 stomach .n-u 2502 to 2604 1 to 103       103/103
(100 %)
0 diff
(100 %id)
BU929319 placenta .n-u 2531 to 3325 1 to 799       799/799
(100 %)
10 diff
(98.8 %id)
AA136743 uterus .n-u 2536 to 3025 1 to 491       491/492
(99 %)
3 diff
(99.4 %id)
BG621779 placenta .n-u 2591 to 3317 1 to 721       721/722
(99 %)
10 diff
(98.7 %id)
CB053454 leiomyosarcoma, soft tissue .n-u 2596 to 2840 1 to 245   fully sequenced,   245/245
(100 %)
6 diff
(97.6 %id)
TI_154103969   .n-u 2601 to 3450 915 to 79   AAA   837/933
(89 %)
14 diff
(98.5 %id)
TI_149297210   .n-u 2618 to 3455 904 to 79   AAA   826/945
(87 %)
15 diff
(98.5 %id)
AW275823 lung, two pooled squamous cell carcinomas .n-u 2630 to 3122 493 to 1       493/493
(100 %)
0 diff
(100 %id)
AW974793   .n-u 2639 to 3245 106 to 712       607/712
(85 %)
6 diff
(99.2 %id)
AW044363 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .n-u 2653 to 3122 470 to 1       470/470
(100 %)
0 diff
(100 %id)
AI493193 uterus .n-u 2659 to 3122 464 to 1       464/464
(100 %)
0 diff
(100 %id)
BF531061 anaplastic oligodendroglioma with 1p/19qloss, brain .n-u 2663 to 3269 1 to 606       606/607
(99 %)
2 diff
(99.7 %id)
AI278317 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n-u 2671 to 3122 452 to 1       452/452
(100 %)
0 diff
(100 %id)
BG260236 bladder, transitional cell papilloma, cell line .n-u 2679 to 3350 1 to 673       673/674
(99 %)
8 diff
(98.9 %id)
BM982318 lung, Primary Lung Cystic Fibrosis EpithelialCells .n-u 2680 to 3455 790 to 19   AAA   772/772
(100 %)
5 diff
(99.4 %id)
TI_154039436   .n-u 2681 to 3517 924 to 110   AAA   815/927
(87 %)
29 diff
(96.9 %id)
BF343269 brain, glioblastoma with EGFR amplification .n-u 2735 to 3450 1 to 711       711/712
(99 %)
10 diff
(98.6 %id)
BQ574530 Chondrosarcoma Grade II, Left Pelvis .n-u 2735 to 3450 734 to 19   AAA   716/716
(100 %)
5 diff
(99.4 %id)
BQ015386 Chondrosarcoma, Left Pubic Bone .n-u 2747 to 3455 726 to 19   AAA   708/708
(100 %)
4 diff
(99.5 %id)
BU185531 ductal carcinoma, cell line, Pancreas .n-u 2750 to 3515 789 to 15     Submitted on the opposite strand 775/974
(79 %)
0 diff
(100 %id)
TI_149279059   .n-u 2757 to 3455 752 to 52   AAA   701/1189
(58 %)
19 diff
(98.5 %id)
CA432352 cell lines, Chondrosarcoma .n-u 2789 to 3455 685 to 19   tiling clone, AAA   667/667
(100 %)
1 diff
(99.9 %id)
BU607880 Human Lung Epithelial cells, lung .n-u 2797 to 3455 677 to 19   AAA   659/659
(100 %)
1 diff
(99.9 %id)
CA446153 Chondrosarcoma, Left Pubic Bone .n-u 2800 to 3450 669 to 19   AAA   651/651
(100 %)
0 diff
(100 %id)
CB053453 leiomyosarcoma, soft tissue .n-u 2810 to 3455 671 to 26   fully sequenced, AAA   646/646
(100 %)
0 diff
(100 %id)
BQ020090 Chondrosarcoma, Left Pubic Bone .n-u 2815 to 3455 658 to 19   AAA   640/640
(100 %)
3 diff
(99.6 %id)
BG620311 placenta .n-u 2845 to 3513 1 to 669   AAA   669/669
(100 %)
4 diff
(99.5 %id)
BU580561 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .n-u 2850 to 3451 605 to 4       602/616
(97 %)
0 diff
(100 %id)
W92819 liver and spleen .n-u 2879 to 3122 244 to 1       244/244
(100 %)
2 diff
(99.2 %id)
BJ997944 Wilms tumor .n-u 2880 to 3419 540 to 1       540/540
(100 %)
1 diff
(99.9 %id)
DB355464 whole embryo, mainly head .n-u 2896 to 3450 555 to 1       555/555
(100 %)
1 diff
(99.9 %id)
DB313838 tongue, tumor tissue .n-u 2909 to 3455 547 to 1       547/547
(100 %)
1 diff
(99.9 %id)
AI074153 Kidney .n-u 2921 to 3515 600 to 6   tiling clone,   595/600
(99 %)
0 diff
(100 %id)
TI_157613479   .n-u 2987 to 3452 558 to 93   AAA   466/470
(99 %)
9 diff
(98.1 %id)
AI336141 lung .n-u 2994 to 3449 456 to 1       456/456
(100 %)
0 diff
(100 %id)
TI_154094272   .n-u 3016 to 3455 532 to 88   AAA   445/851
(52 %)
8 diff
(99.1 %id)
CA436447 Bone, Subchondral Bone .n-u 3048 to 3455 426 to 19   AAA   408/408
(100 %)
0 diff
(100 %id)
AW276185 lung, two pooled squamous cell carcinomas .n-u 3077 to 3453 377 to 1       377/377
(100 %)
0 diff
(100 %id)
TI_159723179   .n-u 3080 to 3610 614 to 84   tiling clone, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 531/1045
(50 %)
2 diff
(99.9 %id)
AA418362 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n-u 3106 to 3469 364 to 1     Submitted on the opposite strand 364/364
(100 %)
0 diff
(100 %id)
AL040990 testis .n-u 3114 to 3395 282 to 1       282/282
(100 %)
0 diff
(100 %id)
AA136611 uterus .n-u 3115 to 3510 397 to 1       397/397
(100 %)
2 diff
(99.5 %id)
AI417511 Prostate .n-u 3118 to 3450 333 to 1       333/333
(100 %)
0 diff
(100 %id)
AA873091 2 pooled tumors (clear cell type), Kidney .n-u 3134 to 3456 323 to 1       323/323
(100 %)
0 diff
(100 %id)
FN155803 breast carcinoma .n-u 3239 to 3348 110 to 1     Submitted on the opposite strand 110/110
(100 %)
0 diff
(100 %id)
AW304203 lung, two pooled squamous cell carcinomas .n-u 3294 to 3455 162 to 1       162/162
(100 %)
0 diff
(100 %id)
CN288069 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .o-u 1 to 571 1 to 571   tiling clone,   571/571
(100 %)
1 diff
(99.9 %id)
BF928938 nervous_tumor .o-u 429 to 525 103 to 7     Submitted on the opposite strand 97/103
(94 %)
0 diff
(100 %id)
BG987255 head_neck .o-u 526 to 1055 539 to 4 R7P Q30P N38H Q50P N56D tiling clone,   536/539
(99 %)
0 diff
(100 %id)
DB340537 testis .o-u 534 to 1065 1 to 532 exact tiling clone, Submitted on the opposite strand 532/532
(100 %)
4 diff
(99.3 %id)
BG005277 placenta_normal .p-u 1 to 477 1 to 476 P4L R5G S7A P8L R9A ... tiling clone,   476/476
(100 %)
4 diff
(99.2 %id)
BG005250 placenta_normal .p-u 19 to 537 1 to 520       520/520
(100 %)
3 diff
(99.5 %id)
BG006584 placenta_normal .p-u 168 to 554 391 to 4   tiling clone,   388/391
(99 %)
0 diff
(100 %id)
BF985692 placenta_normal .p-u 232 to 553 339 to 19       321/339
(94 %)
0 diff
(100 %id)
CA438165 lung, Lung Focal Fibrosis .q-u 1 to 551 18 to 568 exact tiling clone, Submitted on the opposite strand 557/568
(98 %)
6 diff
(99.0 %id)
BG007471 placenta_normal .q-u 66 to 541 476 to 2       475/476
(99 %)
0 diff
(100 %id)
BG002991 placenta_normal .r-u 1 to 353 17 to 370 R2M K3V T4S A5G S6V ... tiling clone,   354/377
(93 %)
6 diff
(98.5 %id)
AK225422 Kidney Gene EGFR, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BC094761 Placenta, normal Gene EGFR, variant not shown       AAA This clone was ignored    
BF738539 bladder_tumor Gene EGFR, variant not shown         This clone was ignored    
TI_149309273   Gene EGFR, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h, .i-u, .j, .k, .l, .m, .n-u, .o-u, .p-u, .q-u, .r-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI